Weight loss drug Wegovy can cure serious liver disease
Thursday, 1 May 2025
A recent clinical trial reveals that Wegovy, a popular weight-loss drug containing semaglutide, shows promising results in treating liver diseases like MASH. The study, published in the New England Journal of Medicine, involved over 800 participants across 37 countries. Wegovy significantly reduced liver inflammation and scarring, offering hope for millions affected by fatty liver diseases.
|
||||
|
|
||||
You Might Like |
||||
